Robust cerebrovascular blood velocity and flow rate estimation from 4D-CTA.
Abstract
PURPOSE: Blood velocity and flow rate information may be helpful for a wide variety of applications, but it often requires separate acquisitions. The dynamic information combined with the high spatial resolution of four-dimensional computed tomography angiography (4D-CTA) offers the possibility to quantify blood flow simultaneous to vascular anatomy.
METHODS: A 4D-CTA clinical protocol with a novel dedicated postprocessing were validated in vitro in a patient-specific model, and tested in a pilot study of six patients. Blood flow was assessed in both internal carotid (ICAs) and vertebral (VAs) arteries by analyzing spatial displacement of contrast agent in the form of time-intensity curves (TICs). Unlike previous approaches, it does not require any a priori assumptions about TIC shape, but rather computes mean velocity and flow rates from the spatial displacement of the TICs along the automatically segmented vessels.
RESULTS: In vitro experiments showed good agreement between 4D-CTA and flowmeter measurements under steady and pulsatile flow conditions. In vivo measurements exhibited large interpatient variability of the TIC shapes, from which blood flow rates could nevertheless be successfully measured in all patients and investigated vessels. On average, measured flow rates were 3.2 ± 0.7 ml/s (in ICAs) and 1.3 ± 0.8 ml/s (in VAs) consistent with previous reference standards. Contrary to our novel approach, which considered the full TIC shape, application of previous…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- In silico toxicology protocols
- Automated in Silico Design of Homogeneous Catalysts
- In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications
- mRNA codon optimization with quantum computers
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.